IMT Header

ImVacS 2015 Distinguished Speaker Faculty

Adam Buckley, MBA, Vice President, Business Development, VBI Vaccines, Inc.
Adrian Bot, M.D., Ph.D., Vice President, Translational Medicine, Kite Pharma, Inc.
Adrian W. Briggs, Ph.D., Director, Molecular Biology R&D, AbVitro
Akshaya Ramesh, Kepler Lab, Genetics and Genomics, Boston University School of Medicine
Alexander Anderson, Ph.D., Chair, Integrated Mathematical Oncology Program, Moffitt Cancer Center
Alexander Marson, M.D., Ph.D., UCSF Sandler Faculty Fellow, Medicine and Diabetes Center, University of California San Francisco
Ali Fattom, Ph.D., Senior Vice President, Vaccine R&D, NanoBio
Amit Mahipal, M.D., Medical Director, Clinical Research Unit; Assistant Member, H. Lee Moffitt Cancer Center & Research Institute
Andrea Facciabene, Ph.D., Research Assistant Professor, Obstetrics and Gynecology, University of Pennsylvania School of Medicine
Andrew M. Scharenberg, M.D., Professor, Pediatrics; Adjunct Professor, Immunology, University of Washington School of Medicine; Co-Director, Program for Cell and Gene Therapy, Seattle Children's Hospital
Annaliesa Anderson, Ph.D., Senior Director, Vaccine Research and Early Development, Pfizer
Anne K. Vallerga, Ph.D., Executive Vice President, Colby Pharmaceuticals
Antu Dey, Ph.D., Senior Scientist, Process & Product Development Leader, GlaxoSmithKline
Arnaud Didierlaurent, Ph.D., Director, Translational Research & Adjuvant, GlaxoSmithKline Vaccines
Aung Naing, M.D., Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center
Barbara Swanson, Ph.D., Director, Research, Sorrento Therapeutics, Inc.
Carmen M. Collazo-Custodio, Ph.D., Microbiology & Primary Reviewer, Vaccines & Related Product Applications, CBER, FDA
Chantale Bernatchez, Ph.D., Assistant Professor, Melanoma Medical Oncology, MD Anderson
Charles L. Sentman, Ph.D., Professor, Microbiology and Immunology; Director, Center for Synthetic Immunity, Geisel School of Medicine, Dartmouth College
Daniel J. Wattendorf, M.D., Col., USAF, MC, Program Manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA)
David A. Zarling, Ph.D., CEO, Colby Pharmaceuticals
David E. Hill, Ph.D., Associate Director, Center for Cancer Systems Biology (CCSB); Principal Scientist, Department of Cancer Biology, Dana-Farber Cancer Institute
David M. Spencer, Ph.D., CSO, Bellicum Pharmaceuticals, Inc.
Deborah Higgins, Ph.D., Scientific Director, RSV Vaccine Project, PATH
Derek O'Hagan, Ph.D., Global Head, Vaccine Chemistry and Formulation Research, GlaxoSmithKline
Elena Spanjaard, Ph.D., Director, Worldwide Research & Development, Regulatory Affairs, Pfizer
Elizabeth Evans, Ph.D., Director, Oncology Research, Vaccinex Inc.
Fei Ann Ran, Ph.D., Post-Doctoral Fellow, Laboratory of Dr. Feng Zhang, Broad Institute; Junior Fellow, Harvard Society of Fellows
G. Grant Welstead, Ph.D., Scientist II, Editas Medicine
Gary K. Lee, Ph.D., Associate Director, Genome Editing, Sangamo BioSciences
Gavin Painter, Ph.D., Science Team Leader, The Ferrier Research Institute, Victoria Institute of Wellington
Guadalupe Cortes-Garcia, Ph.D., Manager, Viral Immunology, Sanofi Pasteur
Gullu Topal Gorgun, Ph.D., Senior Research Scientist, Dana-Farber Cancer Institute
Harjeet Singh, Ph.D., Research Investigator, Pediatrics, MD Anderson Cancer Center
Harpreet Singh, Ph.D., CSO and Managing Director, immatics biotechnologies GmbH
Hing C. Wong, Ph.D., President and CEO, Altor Bioscience
Hinrich Abken, Ph.D., Professor, Cancer Genetics, Internal Medicine, University Hospital of Cologne
Ioanna Skountzou, M.D., Ph.D., Assistant Professor, Microbiology & Immunology, Emory University School of Medicine
Jacqueline Doody, Vice President, Immunology, F-star Biotechnology Ltd.
Jeff T. Hutchins, Ph.D., Vice President, Preclinical Research, Peregrine Pharmaceuticals
Jelveh Lameh, Ph.D., Executive Director, Head BioPharma Services Laboratory, Genoptix Medical Laboratory Inc., a Novartis Company
Jerry McMahon, Ph.D., President & CEO, Kolltan Pharmaceuticals
Matthias A. Oberli, Ph.D., Postdoctoral Fellow, Langer Lab, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Jian Yan, Ph.D., Antigen Design Lead, Inovio Pharmaceuticals
John Haurum, M.D., D.Phil., CEO, F-star GmbH & F-star Biotechnology Ltd.
Julien Valton, Ph.D., R&D Project Leader, Cellectis
Jung Huang, Ph.D., Professor, Biochemistry and Molecular Biology, Saint Louis University School of Medicine
Kai W. Wucherpfennig, M.D., Ph.D., Professor, Dana-Farber Cancer Institute and Harvard Medical School
Kathleen M. Mahoney, M.D., Ph.D., Clinical Instructor, Beth Israel Deaconess Medical Center; Post-Doctoral Fellow, Dana Farber Cancer Institute
Kathryn Stephenson, M.D., MPH, Instructor, Medicine, Center for Virology and Vaccine Research/BIDMC, Harvard Medical School
Kipp A. Weiskopf, Ph.D., Research Scientist, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
Konstantin M. Linnik, Ph.D., Partner, Intellectual Property, Nutter, McClennen & Fish, LLP
Kurt Schalper, M.D., Ph.D., Associate Research Scientist, Pathology, Yale University School of Medicine
Lakshmi Krishnan, Ph.D., Program Leader, Vaccines, and Team Leader, Human Health Therapeutics, National Research Council, Canada
Laszlo Radvanyi, Ph.D., CSO, Lion Biotechnologies
Llew Keltner, M.D., Ph.D., CEO, EPISTAT
Luise U. Weigand, Ph.D., Team Leader, Cell Biology, Immunocore Ltd.
Lynda Tussey, Ph.D., Vice President, R&D, VaxInnate
Marc Mansour, Ph.D., COO, ImmunoVaccine, Canada
Mark Throsby, Ph.D., CSO, Merus
Matthew Porteus, M.D., Ph.D., Associate Professor, Pediatrics, Cancer Biology, Stanford University School of Medicine
Michael A. Postow, M.D., Assistant Attending Physician, Melanoma and Immunotherapeutics Service, Memorial Sloan-Kettering Cancer Center
Michael B. Atkins, M.D., Deputy Director, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
Michael Bethune, Ph.D., Postdoctoral Fellow, Laboratory of David Baltimore, Division of Biology and Biological Engineering, Caltech
Michael C. Jensen, M.D., Janet & Jim Sinegal Endowed Professor, Pediatrics; Adjunct Professor, Bioengineering, University of Washington School of Medicine; Joint Member, Program in Immunology, Fred Hutchinson Cancer Research Center
Nathalie Garcon, Ph.D., Pharm.D., CSO, Bioaster
Omid Hamid, M.D., Director, Melanoma Center, Angeles Clinic and Research Institute
Paul D. Rennert, Founder & Principal, SugarCone Biotech Consultants LLC
Paul F. Robbins, Ph.D., Staff Scientist, Surgery Branch, Center for Cancer Research, National Cancer Institute
Polly C. Matzinger, Ph.D. Senior Investigator, Ghost Lab, Laboratory of Immunogenetics, NAID/NIH
Pramod Srivastava, M.D., Ph.D., Professor, Immunology and Medicine, University of Connecticut School of Medicine; Director, Carole and Ray Neag Comprehensive Cancer Center
Quinton Dowling, Process Development Specialist, Infectious Disease Research Institute
Ravi Madan, M.D., Clinical Director, Genitourinary Malignancies Branch, National Cancer Institute
Reid Rubsamen, M.D., CEO, Flow Pharma
Richard Morgan, Ph.D., Vice President, Immunotherapy, bluebird bio
Rodger Novak, M.D., Ph.D., CEO & Founder, CRISPR Therapeutics
Roger H. Brookes, Ph.D., Bioprocess R&D, Sanofi Pasteur
Ruchi Shah, GlaxoSmithKline Vaccines; Department of Pharmaceutical Sciences, Northeastern University
Ryan M. Kramer, Ph.D., Scientist II, Characterization and Product Development Manager, Infectious Disease Research Institute
Shan Lu, M.D., Ph.D., Professor, Medicine, University of Massachusetts Medical School
Sonia Trepanier, Ph.D., Senior Director, Clinical Studies, Medicago
Sriram Sathy, Ph.D., Director, Translational Sciences, Jounce Therapeutics
Susan Kaech, Ph.D., Associate Professor, Immunobiology, Yale University School of Medicine
Takashi K. Kishimoto, Ph.D., CSO, Selecta Biosciences
Tariq Ghayur, Ph.D., Distinguished Research Fellow, AbbVie Bioresearch Center
Thomas B. Kepler, Ph.D., Professor, Microbiology, Professor, Mathematics and Statistics, Boston University School of Medicine
Timothy Fouts, Ph.D., Senior Director, Virology, Profectus BioSciences
Tong-Ming Fu, Ph.D., Senior Investigator, Merck
Vidyashankara Iyer, Ph.D., Scientist, Formulation Sciences, MedImmune
Weiming Yuan, Ph.D., Assistant Professor, Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California
William Hildebrand, Ph.D., Chief Scientist, Pure MHC, LLC
William Watt, Ph.D., CEO & Co-Founder, EpiThany, Inc.; University of Washington Tumor Vaccine Group

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

2015 IMVACS-The Immunotherapies & Vaccine Summit

Download Brochure 

2015 Final Agenda

View All Sponsors 

View Media Partners 

Exhibit Contract 

ImVacS Attendee Profile Icon 

See Who Attended ImVacS 2014! 

ImVacS Attendee Profile Statistics Attendee Profile: Over 300 international delegates from biotech, pharma, and more attend ImVacS every year. Don't miss networking and collaboration opportunities with vaccine and immunotherapy thought-leaders! View full details here.